Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival

Table 2

Survival characteristics of patients related to their tumoral GPC6 and TMEM132D mRNA levels.

	All	GPC6 mRNA levels		TMEM132D mRNA levels		GPC6/TMEM132D mRNA levels
		Low	High	Low	High	Both low	High GPC6 and/or TMEM132D
N (%)	35	28 (80)	7 (20)	26 (74.3)	9 (25.7)	22 (62.9)	13 (37.1)
Survival
5-year survival (%)	91.34 ± 4.78	88.73 ± 6.13	100	88.29 ± 6.36	100	85.45 ± 7.78	100
10-year survival (%)	84.69 ± 6.34	80.06 ± 8.04	100	78.73 ± 8.55	100	73.62 ± 10.27	100
Overall survival (months)
Mean ± SE	189 ± 12	179 ± 15	Undefined^a	152 ± 13	Undefined^a	144 ± 15	Undefined^a
95% C.I.	164–213	149–209	—	126–177	—	114–174	—
Death cases (%)	6 (17.14%)	6 (21.4)	0 (0)	6 (23.1)	0 (0)	6 (27.3)	0 (0)
value (log-rank test)		0.214		0.099		0.032

^aAll subjects alive.